219 related articles for article (PubMed ID: 12231370)
21. Protective effect of mycophenolate mofetil on endothelial function in an aortic allograft model.
Fréguin-Bouilland C; Godin M; Bellien J; Richard V; Remy-Jouet I; Dautreaux B; Henry JP; Compagnon P; Thuillez C; Plissonnier D; Joannidès R
Transplantation; 2011 Jan; 91(1):35-41. PubMed ID: 21441851
[TBL] [Abstract][Full Text] [Related]
22. Sirolimus and mycophenolate mofetil after liver transplantation.
Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P
Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738
[TBL] [Abstract][Full Text] [Related]
24. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation.
Morales JM; Domínguez-Gil B
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S296-303. PubMed ID: 17130278
[TBL] [Abstract][Full Text] [Related]
25. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.
Schlitt HJ; Barkmann A; Böker KH; Schmidt HH; Emmanouilidis N; Rosenau J; Bahr MJ; Tusch G; Manns MP; Nashan B; Klempnauer J
Lancet; 2001 Feb; 357(9256):587-91. PubMed ID: 11558484
[TBL] [Abstract][Full Text] [Related]
26. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.
Fortin MC; Raymond MA; Madore F; Fugère JA; Pâquet M; St-Louis G; Hébert MJ
Am J Transplant; 2004 Jun; 4(6):946-52. PubMed ID: 15147429
[TBL] [Abstract][Full Text] [Related]
28. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
Boratyńska M; Banasik M; Patrzałek D; Klinger M
Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
Ekberg H; Bernasconi C; Nöldeke J; Yussim A; Mjörnstedt L; Erken U; Ketteler M; Navrátil P
Nephrol Dial Transplant; 2010 Jun; 25(6):2004-10. PubMed ID: 20106825
[TBL] [Abstract][Full Text] [Related]
30. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
31. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Bouchard D; Despatis MA; Buluran J; Cartier R
Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698
[TBL] [Abstract][Full Text] [Related]
32. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
[TBL] [Abstract][Full Text] [Related]
33. Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.
Su VCh; Greanya ED; Ensom MH
Ann Pharmacother; 2011 Feb; 45(2):248-57. PubMed ID: 21304036
[TBL] [Abstract][Full Text] [Related]
34. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
35. Clinically significant drug interactions with new immunosuppressive agents.
Mignat C
Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
37. Hypercholesterolemia increases coronary endothelial dysfunction, lipid content, and accelerated atherosclerosis after heart transplantation.
Perrault LP; Mahlberg F; Breugnot C; Bidouard JP; Villeneuve N; Vilaine JP; Vanhoutte PM
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):728-36. PubMed ID: 10712398
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin in patients with chronic renal allograft dysfunction.
Wu MS; Chang CT; Hung CC
Clin Transplant; 2005 Apr; 19(2):236-42. PubMed ID: 15740561
[TBL] [Abstract][Full Text] [Related]
40. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
